Mahesan Subramaniam: A Visual Guide to Heart Valve Disease
Mahesan Subramaniam, Co-Founder of United Health Tourism, shared a post on LinkedIn:
”A Visual Guide to Heart Valve Disease:
As the most common valvular heart disease, aortic stenosis restricts critical blood flow, turning routine fatigue into a sign of severe cardiac risk.
Aortic valve stenosis (AS) is a serious cardiac condition characterized by the narrowing of the valve that regulates blood flow from the heart’s left chamber to the rest of the body. Often driven by age-related calcium buildup or congenital defects, this condition causes the valve to become stiff and rigid, significantly obstructing circulation. Because symptoms like shortness of breath, fatigue, and chest pain are frequently dismissed as typical signs of aging, many patients remain undiagnosed until the disease reaches a critical stage. Left untreated, the restricted blood flow places immense strain on the heart, eventually leading to heart failure or sudden cardiac events.
Early detection is vital, as the disease progresses from asymptomatic stages to severe impairment requiring medical intervention. Fortunately, advancements in cardiac care have revolutionized how AS is managed, offering hope beyond traditional open-heart surgery. While surgical aortic valve replacement (SAVR) remains a standard, minimally invasive options like Transcatheter Aortic Valve Replacement (TAVR) allow for valve repair with significantly reduced recovery times. By recognizing heart palpitations or fainting spells early, patients can access life-saving treatments that restore blood flow and enhance long-term heart health.
Source
Mayo Clinic. (2023). Aortic valve stenosis. Mayo Foundation for Medical Education and Research.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 16:40William Wallace: Vitamin C and Collagen Work as One Biological System
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc
-
Jun 24, 2026, 15:40Annette Bowyer: The Emerging Role of Extravascular Factor VII in Haemostasis
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss